Biomarker News and Research

RSS

A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.

Sense of smell may hold clues to Lewy body pathology: new evidence emerges

Researchers evaluated the impact of Lewy body (LB) positivity (+) on clinical outcomes such as cognition and smell among cognitively.

20 Jul 2023

Pro-inflammatory cytokine levels and their relation to preeclampsia severity

Researchers examine plasma interleukin-6, vascular cell adhesion molecule-1, and C-reactive protein levels in pregnant women with preeclampsia.

20 Jul 2023

New protein discovered in Alzheimer's brains could lead to better diagnosis and treatment

Alzheimer's is considered a disease of old age, with most people being diagnosed after 65. But the condition actually begins developing out of sight many years before any symptoms emerge.

19 Jul 2023

Finger prick blood sample can detect Alzheimer's biomarkers

Advancements in technology and practice reported for the first time at AAIC 2023 demonstrate the simplicity, transportability and diagnostic value of blood-based biomarkers for Alzheimer's, including the future potential for at-home testing by a patient or a family member.

19 Jul 2023

Older adults see the benefit in cognitive screening, but many have not been tested

Eighty percent of older adults see the benefit of tests that can give an early warning that a person's memory and thinking abilities have started to decline, a new poll of people age 65 to 80 finds.

19 Jul 2023

Study identifies potential immune biomarker for pulmonary tuberculosis: a step towards early detection

Researchers have identified a potential immune biomarker associated with pulmonary TB in active patients compared to controls.

19 Jul 2023

Targeted brain stimulation shows promise for treating TBI-related memory loss

Traumatic brain injury (TBI) has disabled 1 to 2% of the population, and one of their most common disabilities is problems with short-term memory. Electrical stimulation has emerged as a viable tool to improve brain function in people with other neurological disorders.

18 Jul 2023

The prognostic value of PCSK9 levels for predicting major adverse cardiovascular events and mortality in diabetics

Researchers investigate the prognostic value of PCSK9 levels in diabetes patients to predict all-cause mortality and major adverse cardiovascular events.

17 Jul 2023

PhoreMost appoints Professor Peter Parker and Dr Jason Imbriglio to Scientific Advisory Board

PhoreMost Ltd. announced Professor Peter Parker and Dr Jason Imbriglio as members of its Scientific Advisory Board (SAB).

From PhoreMost 17 Jul 2023

New proteomic insights: cerebrospinal fluid biomarkers show promise in detecting dementia with Lewy bodies

Researchers conducted cerebrospinal fluid (CSF) proteome profiling and identified CSF proteins.

17 Jul 2023

Quanterix launches LucentAD Biomarker blood test to aid physician diagnosis of Alzheimer’s disease in patients

Quanterix Corporation, a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced it has launched LucentAD, a test to assist in the evaluation of patients experiencing cognitive symptoms consistent with the early signs of Alzheimer’s disease (AD).

From Quanterix 14 Jul 2023

New biomarker could track progression of Alzheimer's disease

Two pathologies drive the progression of Alzheimer's disease. Early on, amyloid beta plaques lead the way, but around the time cognitive symptoms arise, tau tangles take over as the driving force and cognition steadily declines.

13 Jul 2023

New precision medicine trial shows promise for treating rare brain tumors

Papillary craniopharyngiomas (PCPs) are a rare type of brain tumor that cause substantial morbidity for patients.

13 Jul 2023

Pembrolizumab combination therapies effective for advanced NSCLC, study shows

While pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this therapy. Treatment failure, researchers say, is often caused by differences in the tumor microenvironment.

12 Jul 2023

New AI-aided biosensor developed to detect neurodegenerative diseases

By combining multiple advanced technologies into a single system, EPFL researchers have made a significant step forward in diagnosing neurodegenerative diseases (NDDs) such as Parkinson's disease (PD) and Alzheimer's disease (AD).

12 Jul 2023

New heart cell atlas reveals detailed structure of the human heart

In a new study, published today (12 July) in Nature, researchers have produced the most detailed and comprehensive human Heart Cell Atlas to date, including the specialised tissue of the cardiac conduction system - where the heartbeat originates.

12 Jul 2023

$40.5 million NIA grant to fund study of Alzheimer's disease in Asian Americans and Asian Canadians

A $40.5 million grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), will fund the Asian Cohort for Alzheimer's Disease (ACAD) study at Penn Medicine and 15 other academic research centers across the United States and Canada.

11 Jul 2023

Elevated BMI associated with inferior outcomes to treatment for acute lymphoblastic leukemia

As the United States faces a growing obesity epidemic, scientists are taking a closer look at how body weight can affect health outcomes.

11 Jul 2023

High tumor monocyte content linked to better outcomes for esophageal cancer patients

A Ludwig Cancer Research study has discovered that the presence of relatively high numbers of immune cells known as monocytes in tumors is linked to better outcomes in esophageal cancer patients treated with a combination of chemotherapy and immunotherapy, or immunochemotherapy.

10 Jul 2023

Biomarkers in the brain could redefine mental health conditions

The study of biomarkers in the brain-;powered by cutting-edge machine learning techniques-;could redefine the way mental health conditions are categorized and diagnosed and lead to more effective, personalized treatments.

10 Jul 2023

Biomarker News and Research

Further Reading

Sense of smell may hold clues to Lewy body pathology: new evidence emerges

Pro-inflammatory cytokine levels and their relation to preeclampsia severity

New protein discovered in Alzheimer's brains could lead to better diagnosis and treatment

Finger prick blood sample can detect Alzheimer's biomarkers

Older adults see the benefit in cognitive screening, but many have not been tested

Study identifies potential immune biomarker for pulmonary tuberculosis: a step towards early detection

Targeted brain stimulation shows promise for treating TBI-related memory loss

The prognostic value of PCSK9 levels for predicting major adverse cardiovascular events and mortality in diabetics

PhoreMost appoints Professor Peter Parker and Dr Jason Imbriglio to Scientific Advisory Board

New proteomic insights: cerebrospinal fluid biomarkers show promise in detecting dementia with Lewy bodies

Quanterix launches LucentAD Biomarker blood test to aid physician diagnosis of Alzheimer’s disease in patients

New biomarker could track progression of Alzheimer's disease

New precision medicine trial shows promise for treating rare brain tumors

Pembrolizumab combination therapies effective for advanced NSCLC, study shows

New AI-aided biosensor developed to detect neurodegenerative diseases

New heart cell atlas reveals detailed structure of the human heart

$40.5 million NIA grant to fund study of Alzheimer's disease in Asian Americans and Asian Canadians

Elevated BMI associated with inferior outcomes to treatment for acute lymphoblastic leukemia

High tumor monocyte content linked to better outcomes for esophageal cancer patients

Biomarkers in the brain could redefine mental health conditions

Breaking Barriers: ANDYSMANCLUB's Fight for Men's Mental Health on World Mental Health Day

Arrayed CRISPR Screening for Revolutionizing Target Discovery

Innovations in baculovirus–insect cell expression systems

Latest Life Science News